Drug intelligence / Profile preview

Si-Ni-Tang

Development stage
Phase 2
Lead developer
Changhua Christian Hospital
Modality
Small Molecules
Administration
Oral, Nasogastric Tube
01

Overview

Si-Ni-Tang is a classical Traditional Chinese Medicine (TCM) herbal formula first documented in the ancient medical text *Shanghan Lun*. It is a combination product composed of three primary herbal ingredients: processed *Aconitum carmichaeli* (Fuzi), *Zingiber officinale* (Ganjiang), and *Glycyrrhiza uralensis* (Zhigancao). The formula is traditionally used to treat conditions characterized by 'depletion of Yang Qi' and hemodynamic collapse, such as septic shock, heart failure, and severe diarrhea. Mechanistically, the alkaloids in *Aconitum* (such as higenamine and coryneine) provide cardiotonic, positive inotropic, and vasopressor effects. Simultaneously, the active components in *Zingiber* and *Glycyrrhiza* (such as gingerols and glycyrrhizin) exert potent anti-inflammatory effects by inhibiting the production of pro-inflammatory cytokines like TNF-α and IL-6 and suppressing lipopolysaccharide-induced macrophage activation. Si-Ni-Tang is currently being investigated in clinical trials as an adjunctive therapy to standard care for patients with severe sepsis and septic shock to improve hemodynamic stability and modulate immune function.

Other names
Si-ni-tangShigyaku-toSini-Tang
02

Targets

TNFA (Tumor necrosis factor alpha (soluble))

Beyond the preview

Go deeper on Si-Ni-Tang.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Si-Ni-Tang.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call